Trial
NCT02230930
Treatment of Apomorphine-induced Skin Reactions: a Pilot Study
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Medical Center Groningen
Collaborators
—
Condition
Parkinson's Disease
Intervention
Apomorphine 0.25% (2.5mg/ml)
Why stopped
Delayed inclusion - stopped when 10 patients completed the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-13